Apeiron Ria LLC Heron Therapeutics, Inc. Transaction History
Apeiron Ria LLC
- $349 Million
- Q4 2024
A detailed history of Apeiron Ria LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Apeiron Ria LLC holds 262,542 shares of HRTX stock, worth $582,843. This represents 0.11% of its overall portfolio holdings.
Number of Shares
262,542
Previous 243,542
7.8%
Holding current value
$582,843
Previous $484,000
17.15%
% of portfolio
0.11%
Previous 0.14%
Shares
7 transactions
Others Institutions Holding HRTX
# of Institutions
173Shares Held
114MCall Options Held
2MPut Options Held
32.4K-
Rubric Capital Management LP New York, NY26.7MShares$59.3 Million0.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.5MShares$18.9 Million0.02% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$18.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.16MShares$18.1 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$15.5 Million22.07% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $264M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...